Eglucent 100IU/ml Suspension for Injection

Expert advice for Eglucent Suspension for Injection Humalog may be taken shortly before meals. When necessary, it can be given soon after meals. It should be given by subcutaneous injection or by a continuous subcutaneous infusion pump. Subcutaneous administration should be in the upper arms, thighs, buttocks, or abdomen. Use of injection sites should be rotated so that the same site is not used more than approximately once a month. Injection below the skin of the abdomen results in faster absorption than other injection sites. When administered subcutaneously, care should be taken to ensure that a blood vessel has not been entered. After injection, the site of injection should not be massaged. Do not use if the preparation is no longer clear and colourless, or if it contains particles. The insulin device should be stored at 2°C - 8°C (in a refrigerator). Do not freeze. Do not expose to excessive heat or direct sunlight. Once in use, it may be used for up to 28 days. Hypoglycemia (low blood sugar level) is a common side-effect; learn how to identify and manage its symptoms (sweating, rapid heartbeat, weakness, blurry vision, headache) and teach your family as well.